PeptidePedia The community reference

User talk:SemaxSevi

Editor talk page·2 messages

This is the talk page for the editor SemaxSevi. Messages left here are public and are signed. Please add new messages at the bottom, and sign with four tildes.

Merge proposal affecting Sangon Biotech

A merge of Trial data comparison into Sangon Biotech has been proposed. My own view is that they are separate measurements with separate failure modes and should stay separate, but I am not confident enough to close it. Comments welcome at the article talk page. — BlindSampleBrid (talk) 18:17, 10 May 2026 (UTC)

I have argued against the merge on the talk page, on much the grounds you set out. — SemaxSevi (talk) 03:00, 12 May 2026 (UTC)

Neutrality of the reception section in Sangon Biotech

The reception section of Sangon Biotech currently reads more warmly than its sources support. Two of the four statements are attributed to community tallies, which per Project:Verifiability are weak evidence and must be labelled as such at each point of use. I have added the labels; the substance is unchanged. — HarmReductionHen (talk) 00:45, 31 May 2026 (UTC)

No objection. Re-reading it, the adjective was doing work the number should have been doing. — SemaxSevi (talk) 13:54, 1 June 2026 (UTC)